Trial · NCT07907926
Clinical Trial of Type II Collagen vs. Sodium Hyaluronate Intra-articular Injection in Knee Osteoarthritis
NCT07907926, Not applicable, Completed, ATEMs
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Clinical Trial of Type II Collagen vs. Sodium Hyaluronate Intra-articular Injection in Knee Osteoarthritis. Trials, record NCT07907926. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07907926
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Clinical Trial of Type II Collagen vs. Sodium Hyaluronate Intra-articular Injection in Knee Osteoarthritis
- NCT number
- NCT07907926
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 117 participants, actual
- Lead sponsor
- ATEMs
- Conditions
- Osteoarthritis, Osteoarthritis Knee Pain, Knee Arthritis
- Interventions
- CartiSave, Hyalforte Injection
- First posted
- 2026-10-30
- Last updated
- 2026-10-30
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Changes in 100mm- VAS (during activity) | From Baseline to Week 16 | Knee joint pain during activity is assessed using a 100 mm Visual Analogue Scale (VAS). Scores range from 0 mm (no pain) to 100 mm |
| Secondary | Changes in 100mm- VAS Pain Score (during activity) | From Baseline to Week 4 and 24 | Knee joint pain during activity is assessed using a 100 mm Visual Analogue Scale (VAS). Scores range from 0 mm (no pain) to 100 mm(worst possible pain) |
| Secondary | Changes in 100mm- VAS Pain Score (at rest) | From Baseline to Week 4, 16 and 24 | Resting pain in the target knee is assessed using a 100 mm Visual Analogue Scale (VAS). Scores range from 0 mm to 100 mm |
| Secondary | Changes in K-WOMAC | From Baseline to Week 4, 16 and 24 | Joint symptoms and physical function are assessed using the Korean Western Ontario and McMaster Universities (K-WOMAC) index, comprising pain, stiffness, and physical function subscales. Total scores range from 0 to 96, where lower scores indicate better knee joint health and symptom reduction. |
| Secondary | Changes in SF-36 | From Baseline to Week 4, 16 and 24 | Health-related quality of life is assessed using the 36-Item Short Form Survey(SF-36), which covers physical functioning, bodily pain, general health, vitality, social functioning, and mental health. Scores for each domain range from 0 to 100, where higher scores represent a better health state and higher quality of life. |
| Secondary | Changes in Use of Rescue Medication | From Baseline to Day 0, Week 4, 16 and 24 | The use of rescue medication (acetaminophen) will be assessed based on the average number of tablets taken. Lower usage indicates better pain control. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07907926
GET https://conductscience.org/api/trials/v1/NCT07907926/registered